Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELL | P14151 | 1/20 | 0.62 |
| ▸ | SELP | P16109 | 1/20 | 0.62 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.52 |
| ▸ | PIK3CA | P42336 | 5/20 | 0.50 |
| ▸ | TERT | O14746 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30863510 | 1.00 | SELL (0.62) | SELLSELPHDAC1PIK3CATERT | |
| SCHEMBL5298121 | 0.89 | SELL (0.46) | SELLSELPHDAC1PIK3CAALDH1A1 | |
| SCHEMBL1435291 | 0.83 | ALDH1A1 (0.50) | SELLSELPTERTALDH1A1ALOX15 | |
| SCHEMBL28842145 | 0.83 | SELL (0.48) | SELLSELPHDAC1PIK3CAALDH1A1 | |
| SCHEMBL9492963 | 0.81 | SELL (0.41) | SELLSELPHDAC1PIK3CAALDH1A1 | |
| SCHEMBL8345529 | 0.81 | SELL (0.41) | SELLSELPHDAC1PIK3CAALDH1A1 | |
| SCHEMBL1063407 | 0.79 | SELL (0.68) | SELLSELPHDAC1PIK3CATERT | |
| SCHEMBL28135908 | 0.78 | DPP4 (0.46) | SELLSELPPIK3CAALDH1A1ALOX15 | |
| SCHEMBL6858983 | 0.77 | SELL (0.65) | SELLSELPHDAC1PIK3CATERT | |
| SCHEMBL31236653 | 0.77 | SELL (1.00) | SELLSELPHDAC1PIK3CAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115850225-B | Application of hesperidin and method for semisynthesis preparation of chrysin by using hesperidin derivative | 三原润禾生物科技有限公司 | 2024-06-28 | — | — | CN | disclosed |
| US-7923587-B2 | Anti-oxidant macromonomers and polymers and methods of making and using the same | POLNOX CORPORATION (US) | 2011-04-12 | — | — | US | disclosed |
| EP-1771530-B1 | ANTI-OXIDANT MACROMONOMERS AND POLYMERS AND METHODS OF MAKING AND USING THE SAME | POLNOX CORP (US) | 2009-09-09 | — | — | EP | disclosed |
| US-20080311065-A1 | Anti-oxidant macromonomers and polymers and methods of making and using the same | POLNOX CORPORATION | 2008-12-18 | — | — | US | disclosed |
| EP-1214070-A4 | POLYHYDROXYLATED BENZENE-CONTAINING COMPOUNDS | ARCH DEV CORP (US) | 2008-07-16 | — | — | EP | disclosed |
| EP-1776394-A2 | ANTI-OXIDANT MACROMONOMERS AND POLYMERS AND METHODS OF MAKING AND USING THE SAME | Polnox Corporation (US) | 2007-04-25 | — | — | EP | disclosed |
| EP-1771530-A2 | ANTI-OXIDANT MACROMONOMERS AND POLYMERS AND METHODS OF MAKING AND USING THE SAME | Polnox Corporation (US) | 2007-04-11 | — | — | EP | disclosed |
| US-20060041087-A1 | Anti-oxidant macromonomers and polymers and methods of making and using the same | POLNOX CORPORATION | 2006-02-23 | — | — | US | disclosed |
| US-20060041094-A1 | Anti-oxidant macromonomers and polymers and methods of making and using the same | POLNOX CORPORATION | 2006-02-23 | — | — | US | disclosed |
| WO-2006014674-A2 | ANTI-OXIDANT MACROMONOMERS AND POLYMERS AND METHODS OF MAKING AND USING THE SAME | POLNOX CORPORATION (US) | 2006-02-09 | — | — | WO | disclosed |
| WO-2006014605-A2 | ANTI-OXIDANT MACROMONOMERS AND POLYMERS AND METHODS OF MAKING AND USING THE SAME | POLNOX CORPORATION (US) | 2006-02-09 | — | — | WO | disclosed |
| US-20050113426-A1 | Polyhydroxylated benzene-containing compounds | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-05-26 | — | — | US | disclosed |
| US-6610749-B2 | A method for reducing food intake in a subject and a method for reducing the levels of an endocrine in a subject | ARCH DEVELOPMENT CORPORATION | 2003-08-26 | — | — | US | disclosed |
| US-20030139477-A1 | Polyhydroxylated benzene-containing compounds | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-07-24 | — | — | US | disclosed |
| EP-1214070-A2 | POLYHYDROXYLATED BENZENE-CONTAINING COMPOUNDS | Arch Development Corporation (US) | 2002-06-19 | — | — | EP | disclosed |
| WO-2001060319-A2 | POLYHYDROXYLATED BENZENE-CONTAINING COMPOUNDS | ARCH DEVELOPMENT CORPORATION (US) | 2001-08-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080311065-A1 | Anti-oxidant macromonomers and polymers and methods of making and using the same | GPX4, LPO, GPX1 | SELL 605/4885SELP 411/4885HDAC1 2567/4885 |
| US-20050113426-A1 | Polyhydroxylated benzene-containing compounds | LIPE, PNLIP, LIPA | SELL 3047/4885SELP 3677/4885HDAC1 2063/4885 |
| US-20030139477-A1 | Polyhydroxylated benzene-containing compounds | LIPE, PNLIP, SHBG | SELL 3307/4885SELP 3850/4885HDAC1 1745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.